XRCC3 Thr241Met gene polymorphisms and lung cancer risk: A meta-analysis

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Zhan, Ping ^a   Wang, Qin ^b   Qian, Qian ^a   Yu, Li Ke ^a  

^a NANJING CHEST HOSPITAL   (China)

^b 81 Hospital of PLA   (China)

Author keywords

Lung cancer; Meta analysis; Polymorphism; Susceptibility; XRCC3

Indexed keywords

ALLELE; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; DNA POLYMORPHISM; ETHNICITY; GENETIC HETEROGENEITY; HISTOLOGY; HOMOZYGOTE; HUMAN; LUNG CANCER; ONCOGENE; PRIORITY JOURNAL; SMOKING; WILD TYPE; XRCC3 THR241MET GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG TUMOR; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3; XRCC3 PROTEIN;

DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871724720     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-1     Document Type: Article

References (34)

1. Alberg AJ, Samet JM: Epidemiology of lung cancer. Chest 2003, 123:21-49.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008, 83:584-594.
3. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Thirugnanam A, Tan EH: Never-smokers with lung cancer epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006, 24:2245-2251.
4. Benhamou S, Sarasin A: ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005, 161:1-14.
5. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, et al: Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001, 61:1354-1357.
6. Zhan P, Wang Q, Wei SZ, Wang J, Qian Q, Yu LK, Song Y: ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies. J Thorac Oncol 2010, 5(9):1337-1345.
7. Ji YN, Zhan P, Wang J, Qiu LX, Yu LK: APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis. Mol Biol Rep 2011, 38(7):4537-4543.
8. Tebbs RS, Zhao Y, Tucker JD, et al: Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA 1995, 92:6354-6358.
9. Lee JM, Lee YC, Yang SY, Yang PW, Luh SP, Lee CJ, Chen CJ, Wu MT: Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 2001, 95:240-246.
10. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Cementano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A, Vineis P: XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001, 22:1437-1445.
11. Cochran WG: The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
12. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
13. Der Simonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
14. Tobias A: Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999, 8:15-17.
15. Egger M, Davey Smith G, Schneider M, Minder C: Bias in metaanalysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
16. David-Beabes GL, Lunn RM, London SJ: No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:911-912.
17. Misra RR, Ratnasinghe D, Tangrea JA, et al: Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003, 191:171-178.
18. Wang Y, Liang D, Spitz MR, et al: XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer 2003, 98:1701-1706.
19. Popanda O, Schattenberg T, Phong CT, et al: Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004, 25:2433-2441.
20. Jacobsen NR, Raaschou-Nielsen O, Nexo B, et al: XRCC3 polymorphisms and risk of lung cancer. Cancer Lett 2004, 213:67-72.
21. Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW: Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 2004, 44:74-82.
22. Matullo G, Dunning AM, Guarrera S, et al: DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006, 27:997-1007.
23. Zienolddiny S, Campa D, Lind H, et al: Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27:560-567.
24. Ryk C, Kumar R, Thirumaran RK, Hou SM: Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Canc 2006, 54:285-292.
25. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, et al: Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 2007, 7:162.
26. Zhang ZL, Zhou CC, Zhang J, Tang L, Su B: Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi 2007, 30:936-940.
27. Improta G, Sgambato A, Bianchino G, et al: Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res 2008, 28:2941-2946.
28. Xia W, Zhang Y, Su D, Shi F: Association of single nucleotide polymorphisms of DNA repair gene XRCC3-241 with non-small cell lung cancer. Zhejiang Med J 2008, 30:1291-1293.
29. Osawa K, Miyaishi A, Uchino K, Osawa Y, Inoue N, Nakarai C, Tsutou A, Kido Y, Yoshimura M, Tsubota N, Takahashi J: APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac J Cancer Prev 2010, 11(5):1181-1186.
30. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K: Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 2011, 73(2):138-146. Epub 2010 Dec 30.
31. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y: Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 2012, 7(6):954-962.
32. Hirschhorn JN, Lohmueller K, Byrne E: A comprehensive reviewof genetic association studies. Genet Med 2002, 4:45-61.
33. Sato S, Nakamura Y, Tsuchiya E: Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994, 54:5652-5655.
34. Rodriguez C, Calle EE, Miracle-McMahill HL, Tatham LM, Wingo PA, Thun MJ, Heath CW: Family history and risk of fatal prostate cancer. Epidemiology 1997, 8:653-659.